Key Summary
- The government has also made it illegal to hoard stocks inside the UK.
- IPA claims that blood pressure medicines such as Amlodipine and Ramipril are also in short supply.
- Companies are prioritising other countries to sell their medicines as the NHS is offering them at very low prices.
The Labour government has banned aspirin from being exported following reports of ‘serious and growing’ shortages being faced by pharmacies.
The ban came into force on Saturday (17), and it is also illegal to hoard stocks inside the UK.
The Department of Health and Social Care (DHSC) made the move after chemists warned that manufacturing delays and poor supply were depleting the stocks, The i Paper reports.
The UK stocks of aspirin have been hampered by delays in production, the bulk of which happens in India.
Community Pharmacy England (CPE) has long been warning of the impact of medicines shortages on patients and community pharmacies across England.
The pharmacies’ ability to manage these challenges has been constrained by cash flow and reimbursement pressures, it added.
CPE director of research and insights James Davies said, “Medicine shortages, such as the issues currently affecting the supply of aspirin, remain a significant concern for both patients and community pharmacies.
"Our 2025 Medicines Supply Report found that one in four pharmacy teams spend more than two hours each day sourcing alternatives for their patients, diverting attention from other essential tasks and increasing workload pressures."
The Independent Pharmacies Association (IPA) told The i Paper that popular blood pressure medicines such as Amlodipine and Ramipril were also in short supply.
Regarding the aspirin shortage, the IPA said it was also because the UK Government pays companies very low price for aspirin, hence they are prioritising other countries to sell their medicines, "leaving the UK at the back of the queue.”
The IPA said supplies of aspirin 75mg dispersible tablets - those that can be dissolved in water - were running low because of production delays.
The blood pressure medicine Amlodipine in 5mg and 10mg tablets are also running short because some suppliers have stopped supplying due to low prices, it added.
The IPA claims that Amlodipine costs the NHS as little as 48p, and Aspirin at around 60p, which is "cheaper than a packet of sweets".
The IPA chief executive, Dr Leyla Hannbeck, said when medicines are in short supply, prices shoot up, and pharmacies find them unaffordable to order.












